local_hospital

Centre Hospitalier D'Antibes Juan Les Pins

Address
lock Available on a paid plan

Centre Hospitalier D'Antibes Juan Les Pins

Centre Hospitalier D'Antibes Juan Les Pins is a comprehensive medical research institution conducting diverse clinical investigations across multiple therapeutic domains. The center demonstrates particular expertise in critical care medicine, cardiovascular research, and oncology, with active participation in international multi-center trials evaluating novel therapeutic approaches.

  • Intensive care and emergency medicine, including diabetic ketoacidosis management and cardio-renal protection strategies for ICU patients
  • Cardiovascular disease research, particularly acute myocardial infarction treatment and long-term cardiovascular outcomes
  • Oncology and pharmacogenomics, focusing on personalized cancer therapy optimization in breast cancer
  • Gastroenterology and infectious disease, including eosinophilic esophagitis treatment and antibiotic therapy impact on gut microbiota

The research center's portfolio spans from precision medicine approaches in oncology, evaluating DPD activity's impact on chemotherapy efficacy, to comparative effectiveness studies in critical care settings. Recent initiatives include novel fluid resuscitation protocols for diabetic emergencies, innovative SGLT2 inhibitor applications for post-ICU organ protection, and investigations into osteoarticular infections and erosive osteoarthritis management. This diverse research agenda positions the center at the forefront of translational medicine, bridging laboratory discoveries with bedside clinical applications.

Site Overview

assignment
7
connected trials
corporate_fare
4
sponsors
science
12
IMPs

Activity Indicator

Last 6 months

0
Trials started
-100% vs previous period.
1
Trials started 6–12 months ago
7
Total trials linked
Active
trending_downDeclining-100%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
6
Sponsors (total)
4
Active sponsors
3

Sponsor Network

Top 3 by active trials.

lock +2 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

lock +1 more on a paid plan

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 978 other sites in France

description
Trial volume
7
Outperforms 69% of sites
public
Therapeutic diversity
6areas
Outperforms 76% of sites
groups
Sponsor diversity
4sponsors
Outperforms 62% of sites

Therapeutic Area Benchmark — France

Select a therapeutic area to compare against other sites in France.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: France

Market Share

Country: France

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Centre Hospitalier D'Antibes Juan Les Pins

lock Showing 1 of 7 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A Randomized Controlled Trial Comparing Sodium Chloride and Sodium Lactate in the Management of Severe Diabetic Ketoacidosis in ICU PatientsCentre Hospitalier Universitaire De NicePhase IIIRecruitingOct 2025

IMP list

lock Showing 1 of 12 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Bp1.7881A1Unknown2024-11-292024-11-29

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.